Patient selection criteria of deceased donor liver transplantation for primary biliary cirrhosis (PBC) are almost completely established. The aim of this study was to establish selection criteria for both patients and donors of living donor liver transplantation (LDLT) for PBC. We used univariate an
Analysis of Transplant Outcomes After Five or Six Human Leukocyte Antigen-Mismatched Living Donor Kidney Transplantation
β Scribed by H.S. Lee; M.S. Kim; Y.S. Kim; D.J. Joo; M.K. Ju; S.J. Kim; S.I. Kim; K.H. Huh; K. Park
- Book ID
- 113935315
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 302 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We read with great interest the recent article from the Kyoto group regarding primary biliary cirrhosis (PBC) patients after living donor liver transplantation (LDLT). 1 Of 50 patients, 14 died within 6 months after LDLT, and 9 patients showed recurrence with a median follow-up duration of 36 months
Human leukocyte antigen (HLA) compatibility has no clinically significant impact in cadaveric liver transplantation. Less is known regarding living-donor liver transplantation (LDLT). Our prior analysis of the Organ Procurement and Transplantation Network (OPTN) database suggested a higher graft fai